Though the Medtronic OmniaSecure is the world's smallest defibrillation lead, the product development story isn't one of ...
Medtronic’s MDT acquisition of Covidien has produced a combined company that’s a force to be reckoned with in medical technology. Pairing Medtronic’s diversified product portfolio aimed at a wide ...
Medtronic (NYSE: MDT) announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic surgical procedures.
Medtronic ended its fiscal year with nominal sales growth and a steep profit drop, but analysts who cover the medical device company are confident a windfall is ahead, thanks to a strong lineup of ...
The experiences of one surgeon are raising questions about the costs and risks of a Medtronic Inc. (MDT) bone-growth product, threatening to pressure further the company's spinal business. According ...
Medtronic has historically focused on designing and manufacturing devices to address cardiac care, neurological and spinal conditions, and diabetes. All along, the company has remained focused on its ...
Medtronic unveiled three new additions to its coronary portfolio Monday—a transradial diagnostic catheter and accompanying transradial devices to facilitate the treatment of coronary artery disease ...
Cardinal Health has reached a definitive agreement to buy several of Medtronic’s medical device lines for $6.1 billion in cash. The deal, announced Tuesday, gives Cardinal access to 23 product ...
Is it too late to invest in the stock now that it's gained 23% this year? Let's find out whether Medtronic's shares are a buy heading into 2026. During the second quarter of its fiscal year 2026, ...
Two patients who were injured by Medtronic's controversial Infuse bone graft product will receive a combined $8.45 million in settlements with the University of California Los Angeles, where a doctor ...
Fridley-based Medtronic, Inc., recently received a letter from two U.S. senators requesting information about the use of the company's Infuse bone-growth product and payments it made to clinical ...
Medtronic is buying Covidien in a tax-friendly move, but here are three other reasons the deal makes sense. The two companies have big and growing businesses that complement one another, too. Here are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results